{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:41:46Z","timestamp":1789728106349,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Florida Clinical and Translational Research Institute"},{"name":"NIH award","award":["KL2 TR001429"],"award-info":[{"award-number":["KL2 TR001429"]}]},{"name":"Medtronic, St. Jude (now Abbott), Boston Scientific, Neuropace, and Functional Neuromodulation"},{"DOI":"10.13039\/100000098","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"NPF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013144","name":"Parkinson Alliance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013144","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Smallwood Foundation"},{"name":"Bachmann-Strauss Foundation"},{"DOI":"10.13039\/100008771","name":"Tourette Syndrome Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001364","name":"UF Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PeerView"},{"name":"Prime"},{"name":"QuantiaMD"},{"name":"WebMD"},{"name":"MedNet"},{"name":"Henry Stewart"},{"DOI":"10.13039\/100007139","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000895","name":"ANS\/St. Jude","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.parkreldis.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:45:27Z","timestamp":1502253927000},"page":"13-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"P. Justin","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"De Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martinez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2017.08.006_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1155\/2013\/826742","article-title":"Impulse control disorders in Parkinson's disease: crossroads between neurology, psychiatry and neuroscience","volume":"27","author":"Bugalho","year":"2013","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/jnnp-2013-307214","article-title":"Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up","volume":"86","author":"Amami","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/mds.25735","article-title":"Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?","volume":"28","author":"Okun","year":"2013","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours","volume":"135","author":"Lhomm\u00e9e","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"e29768","DOI":"10.1371\/journal.pone.0029768","article-title":"Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome","volume":"7","author":"Moum","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib9","first-page":"964","article-title":"Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson's disease","volume":"20","author":"Kim","year":"2013","journal-title":"J.\u00a0Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp-2012-302387","article-title":"Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease","volume":"84","author":"Eusebio","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.parkreldis.2011.02.013","article-title":"Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review","volume":"17","author":"Broen","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib12","article-title":"Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects","volume":"2011","author":"Demetriades","year":"2011","journal-title":"Park. Dis."},{"issue":"Suppl 14","key":"10.1016\/j.parkreldis.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1002\/mds.20963","article-title":"Deep brain stimulation: neuropsychological and neuropsychiatric issues","volume":"21","author":"Voon","year":"2006","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000381558","article-title":"The influence of bilateral subthalamic nucleus deep brain stimulation on impulsivity and prepulse inhibition in Parkinson's disease patients","volume":"93","author":"Gee","year":"2015","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114140","article-title":"Acute and chronic mood and apathy outcomes from a randomized study of unilateral STN and GPi DBS","volume":"9","author":"Okun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq165","article-title":"Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery","volume":"133","author":"Nirenberg","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/JCP.0000000000000444","article-title":"Pathological gambling associated with aripiprazole or dopamine replacement therapy: do patients share the same features? A review","volume":"36","author":"Grall-Bronnec","year":"2016","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2016.01.002","article-title":"Impulsivity, stimulant abuse, and dopamine receptor signaling","volume":"76","author":"London","year":"2016","journal-title":"Adv. Pharmacol. San. Diego Calif."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jocn.2012.07.020","article-title":"Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson's disease","volume":"20","author":"Kim","year":"2013","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.26099","article-title":"Management of impulse control disorders in Parkinson's disease: controversies and future approaches","volume":"30","author":"Samuel","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2010.10.005","article-title":"The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease","volume":"17","author":"Walker","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mdc3.12004","article-title":"STN vs. GPi deep brain stimulation: translating the rematch into clinical practice","volume":"1","author":"Williams","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson's disease: recent advances","volume":"24","author":"Voon","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2013.02.011","article-title":"Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task","volume":"245","author":"Aleksandrova","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2004.02.032","article-title":"Premature responding following bilateral stimulation of the rat subthalamic nucleus is amplitude and frequency dependent","volume":"1008","author":"Desbonnet","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.0908189107","article-title":"Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation","volume":"107","author":"Rouaud","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1109\/TNSRE.2014.2330515","article-title":"Characterizing motor and cognitive effects associated with deep brain stimulation in the GPi of hemi-Parkinsonian rats","volume":"22","author":"Summerson","year":"2014","journal-title":"IEEE Trans. Neural Syst. Rehabil. Eng."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.neunet.2006.03.006","article-title":"Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making","volume":"19","author":"Frank","year":"2006","journal-title":"Neural Netw. Off. J. Int. Neural Netw. Soc."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.brs.2016.12.014","article-title":"The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease","volume":"10","author":"Birchall","year":"2017","journal-title":"Brain Stimul."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/13854040802360582","article-title":"Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change","volume":"23","author":"Zahodne","year":"2009","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.parkreldis.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2016.12.070","article-title":"Dopamine agonist withdrawal syndrome: a comprehensive review","volume":"374","author":"Yu","year":"2017","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.parkreldis.2017.08.006_bib34","article-title":"Higher doses of dopamine agonists, impulse control disorders and history of deep brain stimulation (DBS): risk factors for dopamine agonists withdrawal syndrome (DAWS)? [abstract]","volume":"31","author":"Garcia","year":"2016","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T10:44:36Z","timestamp":1668768276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017302870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":34,"alternative-id":["S1353802017302870"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.006","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}